Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Cellebrite DI Ltd.

Cellebrite DI Ltd. (CLBT) Stock Overview

Explore Cellebrite DI Ltd.’s financial performance, market position, analyst ratings, and future outlook.

CLBT●NASDAQ
TechnologySoftware - Infrastructure
$15.64
$0.14(0.89%)
U.S. Market opens in 15h 54m

Cellebrite DI Ltd. (CLBT)

Meyka AI Score

Z

Key Financials

Market Cap3.9B
P/E Ratio53.90
EPS (TTM)$0.39
ROE0.16%
Fundamental Analysis

AI Price Forecasts

1 Month$18.46
3 Months$18.28
1 Year Target$13.73

CLBT Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Cellebrite DI Ltd. (NASDAQ: CLBT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Cellebrite DI Ltd.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CLBT on the NASDAQ shows an RSI of 58.81, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $13.73 for the NASDAQ listing.

Key metrics behind Cellebrite DI Ltd.'s NASDAQ-traded stock include a P/E ratio of 53.90 and a market capitalization of 3.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CLBT on the NASDAQ.

Price Performance (NASDAQ: CLBT)

1-Day Change
-0.89%
5-Day Change
8.24%
1-Month Change
-5.84%
3-Month Change
15.08%
6-Month Change
15.08%
Year-to-Date (YTD) Change
-13.26%
1-Year Change
14.58%
3-Year Change
112.21%
5-Year Change
57.50%
All-Time (Max) Change
61.90%

Contact Information

https://www.cellebrite.com
972 73 394 8000
94 Shlomo Shmelzer Road, Petah Tikva, HM, 4970602

Company Facts

12,850 Employees
IPO DateNov 6, 2020
CountryIL
Actively Trading

Frequently Asked Questions